Literature DB >> 16011674

Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.

S D Kuiken1, R Lindeboom, G N Tytgat, G E Boeckxstaens.   

Abstract

BACKGROUND: Visceral hypersensitivity is considered an important pathophysiological mechanism in irritable bowel syndrome, yet its relationship to symptoms is unclear. AIM: To detect possible associations between symptoms and the presence of hypersensitivity to rectal distension in patients with irritable bowel syndrome.
METHODS: Ninety-two irritable bowel syndrome patients and 17 healthy volunteers underwent a rectal barostat study. The association between specific irritable bowel syndrome symptoms and the presence of hypersensitivity was examined using Area under the Receiver Operating Characteristic curves.
RESULTS: Irritable bowel syndrome patients had significantly lower thresholds for discomfort/pain than healthy volunteers: 24 (18-30) and 30 (27-45) mmHg above minimal distending pressure, respectively. Forty-one patients (45%) showed hypersensitivity to rectal distension. Proportions of patients with different predominant bowel habits were similar in hypersensitive and normosensitive subgroups (diarrhoea predominant: 39 and 41%, respectively; alternating type: 27 and 28%, respectively; constipation predominant: 34 and 31%, respectively). Severe abdominal pain was more frequent in hypersensitive, compared with normosensitive patients (88% vs. 67%, P = 0.02), but none of the individual irritable bowel syndrome symptoms could accurately predict the presence of hypersensitivity, as assessed by Area under the Receiver Operating Characteristic curve analysis.
CONCLUSIONS: Hypersensitive and normosensitive irritable bowel syndrome patients present with comparable, heterogeneous symptomatology. Therefore, selection based on clinical parameters is unlikely to discriminate individual irritable bowel syndrome patients with visceral hypersensitivity from those with normal visceral sensitivity.

Entities:  

Mesh:

Year:  2005        PMID: 16011674     DOI: 10.1111/j.1365-2036.2005.02524.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  24 in total

1.  Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.

Authors:  Uri Ladabaum; Annie Sharabidze; Theodore R Levin; Wei K Zhao; Elaine Chung; Peter Bacchetti; Chengshi Jin; Barbara Grimes; Craig J Pepin
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-16       Impact factor: 11.382

Review 2.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

3.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

Review 4.  Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.

Authors:  Tsukasa Nozu; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2015-05-12       Impact factor: 7.527

Review 5.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 6.  Novel techniques to study visceral hypersensitivity in irritable bowel syndrome.

Authors:  Trinh T Truong; Bruce D Naliboff; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2008-08

Review 7.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

8.  Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome.

Authors:  J-M Sabate; M Veyrac; F Mion; L Siproudhis; P Ducrotte; F Zerbib; J-C Grimaud; M Dapoigny; F Dyard; B Coffin
Journal:  Aliment Pharmacol Ther       Date:  2008-06-09       Impact factor: 8.171

Review 9.  Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work?

Authors:  Xiao-Peng Ma; Jue Hong; Cai-Ping An; Dan Zhang; Yan Huang; Huan-Gan Wu; Cui-Hong Zhang; Sian Meeuwsen
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.